You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oral Fluoropyrimidine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gut Microbiome in Colorectal Cancer

Completed
  • Gastrointestinal Microbiome
  • Neoplasm, Colorectal
    • San Francisco, California
      University of California, San Francisco
    Sep 29, 2022

    Cholangiocarcinoma Trial in Hangzhou (radiofrequency ablation, Chemotherapy drug)

    Recruiting
    • Cholangiocarcinoma
    • radiofrequency ablation
    • Chemotherapy drug
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Aug 25, 2021

    Cholangiocarcinoma Trial in Hangzhou (radiofrequency ablation, S-1, Stent)

    Completed
    • Cholangiocarcinoma
    • radiofrequency ablation
    • +2 more
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Nov 17, 2019

    Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Sep 8, 2023

    Advanced Cancer, Refractory Cancer, Tumor Gastric Trial in United States (PCS6422 and capecitabine)

    Recruiting
    • Advanced Cancer
    • +2 more
    • PCS6422 and capecitabine
    • Omaha, Nebraska
    • +4 more
    Feb 4, 2022

    Ras-mutated Metastatic Colorectal Cancer Trial in Napoli (Bevacizumab, mFOLFOX6 regimen, mOXXEL regimen)

    Recruiting
    • Ras-mutated Metastatic Colorectal Cancer
    • Napoli, Campania, Italy
      Istituto Tumori di Napoli - Fondazione G. Pascale
    Sep 1, 2021

    Advanced Gastric Carcinoma Trial in Seoul (Ferinject, Conservative management)

    Recruiting
    • Advanced Gastric Carcinoma
    • Seoul, Korea, Republic of
      Asan Medical Center
    May 9, 2022

    Cancer, Liver Dysfunction Trial in Singapore (TS-1 combined with cisplatin)

    Recruiting
    • Cancer
    • Liver Dysfunction
    • TS-1 combined with cisplatin
    • Singapore, Singapore
    • +1 more
    Apr 12, 2022

    Carcinoma, Pancreatic Ductal Trial in Shanghai (S1, Oxaliplatin, Irinotecan)

    Recruiting
    • Carcinoma, Pancreatic Ductal
    • Shanghai, Shanghai, China
    • +1 more
    Apr 7, 2021

    Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

    Completed
    • Neoplasms
    • FdCyd + THU
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Cardiovascular Toxicity: Comprehensive Myocardial and Vascular

    Recruiting
    • Cardiovascular Diseases
    • +7 more
    • Cardiovascular magnetic resonance with stress perfusion
    • +4 more
    • London, United Kingdom
      St Bartholomews Hospital
    Sep 15, 2023

    Gastric Cancer Trial in Tianjin (Comparing Hyperthermic Intraperitoneal Chemotherapy, Paclitaxel, S1)

    Recruiting
    • Gastric Cancer
    • Comparing Hyperthermic Intraperitoneal Chemotherapy
    • +2 more
    • Tianjin, Tianjin, China
      Department of Gastrointestinal Medical Oncology, Tianjin Medical
    Jan 26, 2022

    Nasopharyngeal Carcinoma Trial in Beijing (Donafenib)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital of Medical College
    Nov 28, 2022

    Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

    Recruiting
    • Colorectal Neoplasms
    • Gilbert, Arizona
    • +46 more
    Jan 31, 2023

    Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

    Recruiting
    • Colonic Neoplasms
    • +2 more
    • Nanning, Guangxi, China
      The First Affiliated Hospital of Guangxi Medical University
    Nov 9, 2023

    Gastric Cancer Stage Trial in Tianjin (sintilimab, apatinib, S1)

    Recruiting
    • Gastric Cancer Stage
    • Tianjin, Tianjin, China
      Department of Gastrointestinal Medical Oncology, Tianjin Medical
    Jul 5, 2021

    Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

    Completed
    Has Results
    • Gastric Cancer
    • Los Angeles, California
    • +33 more
    Feb 18, 2022

    Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Regorafenib (Stivarga, BAY73-4506)
    • Hyderabad, Andhra Pradesh, India
    • +12 more
    Jan 13, 2023

    Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • mCRC
    • Tislelizumab & Fruquintinib
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 25, 2023

    Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)

    Not yet recruiting
    • Cancer
    • DPYD or UGT1A1 variants
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Dec 20, 2022

    Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

    Recruiting
    • Rectal Cancer
    • Kineret 100 MG in 0.67 ML Prefilled Syringe
    • +3 more
    • Frankfurt, Germany
      University Hospital Goethe University Frankfurt
    Aug 23, 2022

    Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in Copenhagen, Odense

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Copenhagen, Region H, Denmark
    • +1 more
    Aug 10, 2022

    Advanced Rectal Cancer Trial in Seoul (Capecitabine plus temozolomide VS Capecitabine)

    Unknown status
    • Advanced Rectal Cancer
    • Capecitabine plus temozolomide VS Capecitabine
    • Seoul, Songpa, Korea, Republic of
      Asan Medical Center
    Jan 17, 2021

    Switching Fluoropyrimidine Due to Cardiotoxicity Study

    Enrolling by invitation
    • Solid Tumor
    • Odense, Denmark
    • +12 more
    Feb 5, 2020

    Colorectal Carcinoma Trial (Pembrolizumab)

    Completed
    Has Results
    • Colorectal Carcinoma
    • Pembrolizumab
    • (no location specified)
    Mar 29, 2022